投資評等
最後更新日期：2024/12/27
升級(Upgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2014/7/24 | Argus | Hold >> Buy | |
| 2013/10/17 | Robert W. Baird | Neutral >> Outperform | $45 >> $56 |
| 2013/9/30 | Pacific Crest | Sector Perform >> Outperform | 55 |
| 2011/1/25 | Auriga U.S.A | Hold >> Buy | $35 >> $37 |
| 2011/1/20 | Miller Tabak | Hold >> Buy | $24 >> $38 |
| 2010/11/3 | Ticonderoga | Neutral >> Buy | 34 |
| 2010/1/19 | RBC Capital Mkts | Sector Perform >> Outperform | $28 >> $32 |
| 2008/12/18 | Jefferies & Co | Underperform Buy | $17 $22 |
| 2007/7/9 | Robert W. Baird | Neutral Outperform | $30 $37 |
| 2006/4/27 | Robert W. Baird | Neutral Outperform | $29 $37 |
| 2005/5/31 | Caris Company | Above Average->Buy | |
| 2005/3/9 | Wachovia | Mkt Perform->Outperform | |
| 2005/3/9 | Smith Barney Citigroup | Hold->Buy | |
| 2005/3/4 | Robert W. Baird | Neutral->Outperform | |
| 2005/2/10 | Banc of America Sec | Sell->Buy | |
| 2004/11/19 | Pacific Crest | Sector Perform->Outperform | |
| 2004/2/25 | Lehman Brothers | Equal-weight->Overweight | $48 |
| 2004/1/8 | Pacific Growth Equities | Under Weight->Equal Weight | |
| 2003/9/9 | JP Morgan | Neutral -> Overweight | |
| 2003/9/8 | First Albany | Neutral -> Buy | |
| 2003/7/18 | UBS | Neutral -> Buy | 32 |
| 2003/2/20 | Merrill Lynch | Neutral -> Buy | |
| 2003/2/19 | Morgan Stanley | Equal-weight -> Overweight | 30 |
| 2003/1/7 | Prudential | Hold -> Buy | |
| 2002/9/27 | AG Edwards | Hold -> Buy | 22 |
| 2002/9/17 | Needham & Co | Buy -> Strong Buy | 27 |
降級(Downgrade)
| 日期/Date | 券商
Brokerage Firm | 原評等->降級後評等
Upgrade from: -> to: | 新目標價
New Target |
| 2012/3/23 | Auriga | Buy >> Hold | $42 >> $39 |
| 2012/1/19 | Deutsche Bank | Buy >> Hold | $34 >> $38 |
| 2012/1/19 | Miller Tabak | Buy >> Hold | $38 >> $41 |
| 2011/9/20 | Auriga | Buy >> Hold | $35 >> $34 |
| 2010/10/21 | UBS | Buy >> Neutral | $35 >> $28 |
| 2010/9/20 | RBC Capital Mkts | Outperform >> Sector Perform | $36 >> $28 |
| 2009/4/22 | Robert W. Baird | Outperform Neutral | |
| 2005/6/9 | Moors Cabot | Buy->Hold | 36 |
| 2005/6/9 | Robert W. Baird | Outperform->Neutral | |
| 2005/4/22 | First Albany | Buy->Neutral | |
| 2005/2/4 | Prudential | Overweight->Underweight | |
| 2005/1/20 | Caris Company | Buy->Above Average | |
| 2004/12/8 | Banc of America Sec | Neutral->Sell | |
| 2004/9/15 | Wachovia | Outperform >> Mkt Perform | |
| 2004/9/15 | UBS | Buy >> Neutral | $32 |
| 2003/7/14 | Smith Barney Citigroup | Outperform -> In-line | |
| 2003/6/3 | Soundview Technology | Outperform -> Neutral | |
| 2003/5/30 | Morgan Stanley | Overweight -> Equal-weight | |
| 2003/3/19 | Pacific Growth Equities | Equal Weight -> Under Weight | |
| 2003/3/18 | First Albany | Buy -> Neutral | |
| 2002/12/6 | Thomas Weisel | Buy -> Attractive | |
| 2002/11/7 | AG Edwards | Buy -> Hold | |
首次予以評等(Coverage Initiated)
| 日期/Date | 券商
Brokerage Firm | 原評等->升級後評等
Upgrade from: -> to: | 目標股價 |
| 2013/3/8 | Argus | Hold | |
| 2011/12/21 | MKM Partners | Neutral | 29 |
| 2011/9/26 | William Blair | Outperform | |
| 2010/10/25 | Deutsche Bank | Buy | 32 |
| 2010/10/1 | Auriga U.S.A | Hold | 29 |
| 2010/1/15 | Broadpoint AmTech Research | Buy | 30 |
| 2009/11/20 | BMO Capital Markets | Market Perform | |
| 2007/5/10 | Deutsche Securities | Buy | 38 |
| 2006/4/7 | Stifel Nicolaus | Buy | 30 |
| 2005/9/26 | Am Tech/JSA Research | Buy | 32 |
恢復投資評等(Coverage Resumed)
| 日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
| 2011/4/13 | Auriga U.S.A | Buy | $37 >> $36 |
| 2010/2/24 | Stifel Nicolaus | Hold | |
| 2009/10/15 | Credit Suisse | Neutral | 25 |
| 2003/8/15 | Merrill Lynch | Buy | 35 |
| 2002/11/12 | Merrill Lynch | Neutral | |
重申相同投資評等(Coverage Reiterated)
| 日期/Date | 券商
Brokerage Firm | 重申相同投資評等
Reiterated Rating | 新目標價
New Target |
| 2015/10/15 | Argus | Buy | $50 >> $55 |
| 2013/3/6 | Deutsche Bank | Hold | $35 >> $37 |
| 2011/10/20 | Barclays Capital | Equal Weight | $33 >> $35 |
| 2011/10/17 | Barclays Capital | Equal Weight | $36 >> $33 |
| 2011/9/12 | Auriga | Buy | $39 >> $35 |
| 2011/4/28 | Auriga U.S.A | Buy | $36 >> $39 |
| 2011/3/3 | UBS | Neutral | $30.50 >> $34.50 |
| 2011/1/20 | UBS | Neutral | $28 >> $30.50 |
| 2011/1/20 | Barclays Capital | Overweight | $31 >> $34 |
| 2011/1/20 | RBC Capital Mkts | Sector Perform | $30 >> $32 |